Literature DB >> 23390630

MR imaging for the prediction of breast cancer response to neoadjuvant chemotherapy.

Nola Hylton.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23390630     DOI: 10.1148/radiol.12124051

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  2 in total

1.  The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO.

Authors:  S Di Cosimo; C Campbell; H A Azim; G Galli; G Bregni; G Curigliano; C Criscitiello; M Izquierdo; L de la Pena; D Fumagalli; L Fein; J Vinholes; W M J Ng; M Colleoni; A Ferro; B J Naume; A Patel; J Huober; M J Piccart-Gebhart; J Baselga; E de Azambuja
Journal:  Eur J Cancer       Date:  2017-12-08       Impact factor: 9.162

2.  Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk.

Authors:  Mark Jesus M Magbanua; Wen Li; Denise M Wolf; Christina Yau; Gillian L Hirst; Lamorna Brown Swigart; David C Newitt; Jessica Gibbs; Amy L Delson; Ekaterina Kalashnikova; Alexey Aleshin; Bernhard Zimmermann; A Jo Chien; Debu Tripathy; Laura Esserman; Nola Hylton; Laura van 't Veer
Journal:  NPJ Breast Cancer       Date:  2021-03-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.